Related Experiment Video
Updated: Apr 19, 2026

10:02
Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells
Published on: June 10, 2022
2.8K
Lipid-based mRNA vaccine delivery systems.
Patrick Midoux1, Chantal Pichon
1Centre de Biophysique Moléculaire, CNRS UPR4301, Inserm and Université d'Orléans, Orléans, 45071, cedex 02, France.
Expert Review of Vaccines
|December 27, 2014
Summary
Synthetic messenger RNAs (mRNAs) show promise for vaccines against cancer and infections. Lipid-based formulations enhance mRNA delivery to dendritic cells, improving immune responses and reducing required doses.
Area of Science:
- Biopharmaceutics
- Vaccinology
- Immunology
Background:
- Synthetic messenger RNAs (mRNAs) are emerging as potent biopharmaceuticals for vaccines.
- Clinical trials show direct mRNA administration is safe and elicits tumor-specific immunity.
- Formulating mRNAs with carriers can enhance specificity and dendritic cell (DC) uptake.
Purpose of the Study:
- To review lipid-based formulations (LBFs) for synthetic mRNA delivery.
- To discuss strategies for selective mRNA LBF delivery to DCs.
- To explore methods for efficient intracellular mRNA translation.
Main Methods:
- Review of preclinical studies on mRNA LBFs.
- Analysis of strategies for targeting LBFs to DCs using carbohydrates or glycomimetics.
- Investigation of pH-sensitive lipids/polymers for endosomal escape.
Main Results:
- Lipid-based formulations (LBFs) demonstrate preclinical efficacy for mRNA delivery.
- Decorating LBFs with carbohydrates enhances DC endocytosis and intracellular accumulation.
- pH-sensitive materials facilitate mRNA escape from endosomes for improved translation.
Conclusions:
- mRNA LBFs offer a promising platform for enhanced vaccination strategies.
- Targeted delivery to DCs via LBFs can improve immune responses and reduce dosage.
- Efficient endosomal escape is crucial for maximizing mRNA translation and therapeutic effect.
Keywords:
RNA vaccinesdendritic cellsglycomimeticsglycotargetinghistidinelipid-based formulationslipoplexeslipopolyplexesmannose receptorspH-sensitive deliveryMore Related Videos
Related Concept Videos
Microorganisms in Medicine and Therapeutics
1.5K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.5K
Modified-Release Drug Delivery Systems: Site-Targeted
144
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
144
Site-Targeted Drug Delivery Systems: Polymeric Carriers
132
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
132

